Melanocortin receptors, melanotropic peptides and penile erection

Stephen H. King, Alexander V. Mayorov, Preeti Balse-Srinivasan, Victor J Hruby, Todd W Vanderah, Hunter Wessells

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Penile erection is a complex physiologic event resulting from the interactions of the nervous system on a highly specialized vascular organ. Activation of central nervous system melanocortinergic (MC) receptors with either endogenous or synthetic melanotropic ligands may initiate and/or facilitate spontaneous penile erection. While the CNS contains principally the MC3 and MC4 receptor subtypes, there is conflicting data as to which receptor mediates erection. Although the MC4R is emerging as the principle effector of MC induced erection, the role of the MC3R is poorly understood. Manipulation of each receptor subtype with newly synthesized receptor specific agonists and antagonists, as well as knockout mice, has elucidated their individual contributions. Novel data from our laboratories suggests that antagonism of forebrain MC3R may enhance melanocortin-induced erections. Furthermore, melanocortin agents may interact with better-studied systems such as oxytocinergic pathways at the hypothalamic, brainstem or spinal level. Current therapies for erectile dysfunction target end organ vascular tissue. Manipulation of MC receptors may provide an alternative, centrally mediated therapeutic approach for erectile and other sexual dysfunctions. The non-specific "superpotent" MC agonist, PT-141, which is the carboxylate derivative of MT-II, has reached phase II human trials. Through their centrally mediated activity, melanocortin agonists have potential to treat erectile dysfunction as well as possible applications to the unmet medical needs of decreased sexual motivation and loss of libido.

Original languageEnglish (US)
Pages (from-to)1111-1119
Number of pages9
JournalCurrent Topics in Medicinal Chemistry
Volume7
Issue number11
StatePublished - Jun 2007

Fingerprint

Melanocortin Receptors
Melanocortins
Penile Erection
Neurology
Erectile Dysfunction
Peptides
Blood Vessels
Receptor, Melanocortin, Type 3
Receptor, Melanocortin, Type 4
Libido
Prosencephalon
Knockout Mice
Nervous System
Brain Stem
Motivation
Central Nervous System
Chemical activation
Tissue
Ligands
Derivatives

Keywords

  • Erectogenic
  • Hindbrain melanocortin signaling
  • Melanotan-II
  • Npgi neurons
  • Pt-141
  • Thiq

ASJC Scopus subject areas

  • Medicine(all)
  • Chemistry(all)

Cite this

King, S. H., Mayorov, A. V., Balse-Srinivasan, P., Hruby, V. J., Vanderah, T. W., & Wessells, H. (2007). Melanocortin receptors, melanotropic peptides and penile erection. Current Topics in Medicinal Chemistry, 7(11), 1111-1119.

Melanocortin receptors, melanotropic peptides and penile erection. / King, Stephen H.; Mayorov, Alexander V.; Balse-Srinivasan, Preeti; Hruby, Victor J; Vanderah, Todd W; Wessells, Hunter.

In: Current Topics in Medicinal Chemistry, Vol. 7, No. 11, 06.2007, p. 1111-1119.

Research output: Contribution to journalArticle

King, SH, Mayorov, AV, Balse-Srinivasan, P, Hruby, VJ, Vanderah, TW & Wessells, H 2007, 'Melanocortin receptors, melanotropic peptides and penile erection', Current Topics in Medicinal Chemistry, vol. 7, no. 11, pp. 1111-1119.
King, Stephen H. ; Mayorov, Alexander V. ; Balse-Srinivasan, Preeti ; Hruby, Victor J ; Vanderah, Todd W ; Wessells, Hunter. / Melanocortin receptors, melanotropic peptides and penile erection. In: Current Topics in Medicinal Chemistry. 2007 ; Vol. 7, No. 11. pp. 1111-1119.
@article{43e0a59813c643f5b5cfd7e0ff647302,
title = "Melanocortin receptors, melanotropic peptides and penile erection",
abstract = "Penile erection is a complex physiologic event resulting from the interactions of the nervous system on a highly specialized vascular organ. Activation of central nervous system melanocortinergic (MC) receptors with either endogenous or synthetic melanotropic ligands may initiate and/or facilitate spontaneous penile erection. While the CNS contains principally the MC3 and MC4 receptor subtypes, there is conflicting data as to which receptor mediates erection. Although the MC4R is emerging as the principle effector of MC induced erection, the role of the MC3R is poorly understood. Manipulation of each receptor subtype with newly synthesized receptor specific agonists and antagonists, as well as knockout mice, has elucidated their individual contributions. Novel data from our laboratories suggests that antagonism of forebrain MC3R may enhance melanocortin-induced erections. Furthermore, melanocortin agents may interact with better-studied systems such as oxytocinergic pathways at the hypothalamic, brainstem or spinal level. Current therapies for erectile dysfunction target end organ vascular tissue. Manipulation of MC receptors may provide an alternative, centrally mediated therapeutic approach for erectile and other sexual dysfunctions. The non-specific {"}superpotent{"} MC agonist, PT-141, which is the carboxylate derivative of MT-II, has reached phase II human trials. Through their centrally mediated activity, melanocortin agonists have potential to treat erectile dysfunction as well as possible applications to the unmet medical needs of decreased sexual motivation and loss of libido.",
keywords = "Erectogenic, Hindbrain melanocortin signaling, Melanotan-II, Npgi neurons, Pt-141, Thiq",
author = "King, {Stephen H.} and Mayorov, {Alexander V.} and Preeti Balse-Srinivasan and Hruby, {Victor J} and Vanderah, {Todd W} and Hunter Wessells",
year = "2007",
month = "6",
language = "English (US)",
volume = "7",
pages = "1111--1119",
journal = "Current Topics in Medicinal Chemistry",
issn = "1568-0266",
publisher = "Bentham Science Publishers B.V.",
number = "11",

}

TY - JOUR

T1 - Melanocortin receptors, melanotropic peptides and penile erection

AU - King, Stephen H.

AU - Mayorov, Alexander V.

AU - Balse-Srinivasan, Preeti

AU - Hruby, Victor J

AU - Vanderah, Todd W

AU - Wessells, Hunter

PY - 2007/6

Y1 - 2007/6

N2 - Penile erection is a complex physiologic event resulting from the interactions of the nervous system on a highly specialized vascular organ. Activation of central nervous system melanocortinergic (MC) receptors with either endogenous or synthetic melanotropic ligands may initiate and/or facilitate spontaneous penile erection. While the CNS contains principally the MC3 and MC4 receptor subtypes, there is conflicting data as to which receptor mediates erection. Although the MC4R is emerging as the principle effector of MC induced erection, the role of the MC3R is poorly understood. Manipulation of each receptor subtype with newly synthesized receptor specific agonists and antagonists, as well as knockout mice, has elucidated their individual contributions. Novel data from our laboratories suggests that antagonism of forebrain MC3R may enhance melanocortin-induced erections. Furthermore, melanocortin agents may interact with better-studied systems such as oxytocinergic pathways at the hypothalamic, brainstem or spinal level. Current therapies for erectile dysfunction target end organ vascular tissue. Manipulation of MC receptors may provide an alternative, centrally mediated therapeutic approach for erectile and other sexual dysfunctions. The non-specific "superpotent" MC agonist, PT-141, which is the carboxylate derivative of MT-II, has reached phase II human trials. Through their centrally mediated activity, melanocortin agonists have potential to treat erectile dysfunction as well as possible applications to the unmet medical needs of decreased sexual motivation and loss of libido.

AB - Penile erection is a complex physiologic event resulting from the interactions of the nervous system on a highly specialized vascular organ. Activation of central nervous system melanocortinergic (MC) receptors with either endogenous or synthetic melanotropic ligands may initiate and/or facilitate spontaneous penile erection. While the CNS contains principally the MC3 and MC4 receptor subtypes, there is conflicting data as to which receptor mediates erection. Although the MC4R is emerging as the principle effector of MC induced erection, the role of the MC3R is poorly understood. Manipulation of each receptor subtype with newly synthesized receptor specific agonists and antagonists, as well as knockout mice, has elucidated their individual contributions. Novel data from our laboratories suggests that antagonism of forebrain MC3R may enhance melanocortin-induced erections. Furthermore, melanocortin agents may interact with better-studied systems such as oxytocinergic pathways at the hypothalamic, brainstem or spinal level. Current therapies for erectile dysfunction target end organ vascular tissue. Manipulation of MC receptors may provide an alternative, centrally mediated therapeutic approach for erectile and other sexual dysfunctions. The non-specific "superpotent" MC agonist, PT-141, which is the carboxylate derivative of MT-II, has reached phase II human trials. Through their centrally mediated activity, melanocortin agonists have potential to treat erectile dysfunction as well as possible applications to the unmet medical needs of decreased sexual motivation and loss of libido.

KW - Erectogenic

KW - Hindbrain melanocortin signaling

KW - Melanotan-II

KW - Npgi neurons

KW - Pt-141

KW - Thiq

UR - http://www.scopus.com/inward/record.url?scp=34447269241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447269241&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 1111

EP - 1119

JO - Current Topics in Medicinal Chemistry

JF - Current Topics in Medicinal Chemistry

SN - 1568-0266

IS - 11

ER -